Celltrion Offers Real-World Data On Rituximab
Presents New Data On Truxima Biosimilar In Diffuse Large B-cell Lymphoma Patients
• By Akriti Seth
Celltrion’s rituximab is found to be safe for patients with diffuse large B-cell lymphoma • Source: Alamy 
